4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-24-033703
Options or other derivatives
- CEO and President acquired 258,590 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KLEMP WALTER V CEO and President | 2024-11-04 | Grant or award · Stock option (right to buy) | +100,000 | 213,152 | D | ||
| KLEMP WALTER V CEO and President | 2024-11-04 | Grant or award · Restricted Stock Units | +115,000 | 328,152 | D | ||
| KLEMP WALTER V CEO and President | 2024-10-25 | Grant or award · Performance Based Restricted Stock Units | +43,590 | 371,742 | D | ||
Loading xslF345X05/rdgdoc.xml…